Kaifie, A.
,
Isfort, S.
Gattermann, N.
Hollburg, W.
Klausmann, M.
Wolf, D.
Maintz, C.
Hänel, M.
Goekkurt, E.
Göthert, J. R.
Platzbecker, U.
Geer, T.
Parmentier, S.
Jost, E.
Serve, H.
Ehninger, G.
Berdel, W. E.
Brümmendorf, T. H.
Koschmieder, Steffen
Funding for this research was provided by:
Novartis Pharma (The SAL-MPN registry had an initial funding from Novartis Pharma GmbH, Nürnberg, Germany.)